Anemia
Anemia
Advertisement
Patrick DalyAnemia | April 5, 2024
The MAA for RP-L102, an investigational gene therapy for Fanconi anemia, has been approved by the EMA.
Read More
Anjali Sharathkumar, MDAnemia | April 5, 2024
Dr. Sharathkumar shared data from her 2024 ASPHO presentation on romiplostim in children with severe aplastic anemia and MDS.
Patrick DalyAnemia | April 3, 2024
The European Commission approved an expanded indication for luspatercept as first-line therapy for anemia in lower-risk MDS.
Patrick DalyAnemia | March 29, 2024
The US FDA has approved vadadustat to treat anemia due to CKD in adults who have been on dialysis for at least three months.
Patrick DalyAnemia | March 22, 2024
The US FDA ODAC voted that the benefits of imetelstat for managing anemia in lower-risk MDS outweigh the risks.
Patrick DalyPNH | March 20, 2024
Iptacopan monotherapy improved hematologic and clinical outcomes of persistent anemia in patients with PNH.
Melissa BadamoAnemia | March 18, 2024
The researchers evaluated surveys sent between 2015 and 2023 to patients with severe aplastic anemia who underwent HSCT.
Melissa BadamoAnemia | March 11, 2024
Requiring dialysis before HSCT is associated with “very poor outcomes,” according to the study.
Patrick DalyAnemia | March 14, 2024
Fludarabine, cyclophosphamide, and ATG had superior outcomes versus historical outcomes of non-ATG conditioning.
Heme Today Staff WritersAnemia | February 26, 2024
This would be the fourth authorized indication for luspatercept in the European Union.
Patrick DalyAnemia | February 22, 2024
HSCT with a matched unrelated or haploidentical donor was a promising alternative in patients with severe aplastic anemia.
Melissa BadamoSickle Cell Disease | February 21, 2024
Hydroxyurea therapy reduced blood transfusion by 75% among pediatric patients in sub-Saharan Africa with sickle cell anemia.
Patrick DalyAnemia | February 21, 2024
Low hemoglobin and anemia were found to be modifiable risk factors associated with low cognitive function in older patients.
Patrick DalyAnemia | February 14, 2024
C1-inhibitor administration during transfusions did not significantly suppress hemolysis in autoimmune hemolytic anemia.
Patrick DalyAnemia | February 5, 2024
Iron deficiency anemia was associated with subsequent diagnosis of gastrointestinal cancers, particularly colorectal cancer.
Melissa BadamoAnemia | February 8, 2024
Letermovir reduced the rate of CMV infection within the first 100 days of transplant.
Patrick DalyAnemia | January 29, 2024
Hypoxia-inducible factor-prolyl hydroxylase domain inhibitors may be a safer and more effective alternative to ESAs.
Patrick DalyAnemia | February 13, 2024
IL-1β inhibition via canakinumab appears feasible as treatment for patients with concurrent anemia and clonal hematopoiesis.
Patrick DalyPNH | January 10, 2024
Danicopan added to C5 inhibitor therapy led to significantly improved hemoglobin concentrations in patients with PNH.
Patrick DalyHematology | February 16, 2024
Dr. Masarova spoke with HemeToday on findings from a treatment comparison of pacritinib and momelotinib in myelofibrosis.
Advertisement
Advertisement
Advertisement
Latest News

April 12, 2024